Skip to content
DataLookout
Menu

GYDECATNCT05924217

Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 7 words Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 75 participants (planned 300)
    • Study completion date changed from estimate of Jun 30, 2026 to Dec 8, 2025
    • Secondary endpoints: details revised at 1 of 1 entry
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Dec 31, 2024 to Jan 1, 2025
    • Study completion date: Dec 31, 2024 to Jun 30, 2026
    • Site details revised
    v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2023 to Jan 2, 2024
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

prevalence of transgender men who have ever been screened for cervical cancer in their lifetime
Timeframe: At study entry, basline (no follow-up)

Secondary (1)

prevalence of transgender men who feel concerned about cervical cancer screening

Arms and interventions

Other: Survey questionnaire

Sites

1 site in 1 country

  • CHU de NîmesNîmes, France